Acromicric Dysplasia Caused by a Novel Heterozygous Mutation of FBN1 and Effects of Growth Hormone Treatment.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27834076)

Published in Ann Lab Med on January 01, 2017

Authors

Hyung Suk Jin1, Ho Young Song2, Sung Yoon Cho3, Chang Seok Ki4, Song Hyun Yang1, Ok Hwa Kim5, Su Jin Kim6

Author Affiliations

1: Green Cross Laboratories, Yongin, Korea.
2: Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea.
3: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
4: Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
5: Department of Radiology, Woorisoa Children's Hospital, Seoul, Korea.
6: Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea. sjkim0128@mjh.or.kr.